Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

(MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive…

Source link : https://www.medpagetoday.com/meetingcoverage/auavideopearls/115825

Author :

Publish date : 2025-05-30 17:50:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

CDC Now Advises Shared Decision-Making for Kids’ COVID Shots

COVID Vaccine Guidance in Pregnancy Has Shifted — But the Science Hasn’t

Related Posts

Preeclampsia Prediction Moving Closer to Reality

‘I Became so Quiet’: When Physicians Attempt Suicide

Why is it so hard to say no?

Cameras that work like our eyes could give boost to astronomers

CRC Risk Lower With Positive FIT and Follow-Up Colonoscopy

Are Caregivers Adequately Prepared to Manage Food Allergies?

Preeclampsia Prediction Moving Closer to Reality

‘I Became so Quiet’: When Physicians Attempt Suicide

Why is it so hard to say no?

Cameras that work like our eyes could give boost to astronomers

CRC Risk Lower With Positive FIT and Follow-Up Colonoscopy

Are Caregivers Adequately Prepared to Manage Food Allergies?

The New Scientist Book Club’s verdict on Lake of Darkness by Adam Roberts: A mixed bag

Alex Foster on his new novel, which imagines what it would feel like to be on a planet spinning out of control

Categories

Archives